# Low-dose Radiotherapy Combined With Conventional Fractionated Radiotherapy in Lung Cancer After Immunotherapy Resistance

> **NCT05906329** · NA · UNKNOWN · sponsor: **Qianfoshan Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Cancer Patients

## Interventions

- **RADIATION:** Low-dose radiotherapy combined with conventional fractionated radiotherapy

## Key facts

- **NCT ID:** NCT05906329
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-31
- **Primary completion:** 2023-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05906329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05906329, "Low-dose Radiotherapy Combined With Conventional Fractionated Radiotherapy in Lung Cancer After Immunotherapy Resistance". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05906329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*